195 related articles for article (PubMed ID: 33805673)
1. Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells.
Kurasaka C; Ogino Y; Sato A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805673
[TBL] [Abstract][Full Text] [Related]
2. Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil.
Kurasaka C; Nishizawa N; Ogino Y; Sato A
ACS Omega; 2022 Feb; 7(7):6046-6052. PubMed ID: 35224365
[TBL] [Abstract][Full Text] [Related]
3. Relationship between anticancer sensitivities and cellular respiration properties in 5-fluorouracil-resistant HCT116 human colorectal cancer cells.
Kurasaka C; Nishizawa N; Uozumi H; Ogino Y; Sato A
FEBS Open Bio; 2023 Jun; 13(6):1125-1133. PubMed ID: 37058332
[TBL] [Abstract][Full Text] [Related]
4. Resistance of colorectal cancer cells to 5-FUdR and 5-FU caused by Mycoplasma infection.
Jetté L; Bissoon-Haqqani S; Le François B; Maroun JA; Birnboim HC
Anticancer Res; 2008; 28(4B):2175-80. PubMed ID: 18751392
[TBL] [Abstract][Full Text] [Related]
5. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
6. The role of thymidylate synthase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells.
Oguri T; Achiwa H; Bessho Y; Muramatsu H; Maeda H; Niimi T; Sato S; Ueda R
Lung Cancer; 2005 Sep; 49(3):345-51. PubMed ID: 15993511
[TBL] [Abstract][Full Text] [Related]
7.
Kang YH; Lee JS; Lee NH; Kim SH; Seo CS; Son CG
Molecules; 2021 Mar; 26(7):. PubMed ID: 33806077
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
[TBL] [Abstract][Full Text] [Related]
9. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
10. Regulation of 5-fluorodeoxyuridine monophosphate-thymidylate synthase ternary complex levels by autophagy confers resistance to 5-fluorouracil.
Nishizawa N; Kurasaka C; Ogino Y; Sato A
FASEB Bioadv; 2023 Jan; 5(1):43-51. PubMed ID: 36643896
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
Inaba M; Naoe Y; Mitsuhashi J
Biol Pharm Bull; 1998 Jun; 21(6):569-73. PubMed ID: 9657039
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Thymidylate Synthase and Methylenetetrahydrofolate Reductase Genotypes on Sensitivity to 5-Fluorouracil Treatment in Colorectal Cancer Cells.
Naghibalhossaini F; Shefaghat M; Mansouri A; Jaberi H; Tatar M; Eftekhar E
Acta Med Iran; 2017 Dec; 55(12):751-758. PubMed ID: 29373881
[TBL] [Abstract][Full Text] [Related]
13. Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells.
Nabeya Y; Suzuki T; Furuya A; Koide N; Ohkoshi M; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
Cancer Sci; 2011 Aug; 102(8):1509-15. PubMed ID: 21561529
[TBL] [Abstract][Full Text] [Related]
14. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
Sakatani A; Sonohara F; Goel A
Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
[TBL] [Abstract][Full Text] [Related]
15. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
[TBL] [Abstract][Full Text] [Related]
16. Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence.
Brody JR; Hucl T; Costantino CL; Eshleman JR; Gallmeier E; Zhu H; van der Heijden MS; Winter JM; Wikiewicz AK; Yeo CJ; Kern SE
Cancer Res; 2009 Feb; 69(3):984-91. PubMed ID: 19155291
[TBL] [Abstract][Full Text] [Related]
17. Anticancer sensitivity and biological aspect of 5-fluorouracil-resistant human colorectal cancer HCT116 cells in three-dimensional culture under high- and low-glucose conditions.
Kurasaka C; Nishizawa N; Ogino Y; Sato A
Nucleosides Nucleotides Nucleic Acids; 2024 Mar; ():1-11. PubMed ID: 38555594
[TBL] [Abstract][Full Text] [Related]
18. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase.
Milczarek M; Rossowska J; Klopotowska D; Stachowicz M; Kutner A; Wietrzyk J
J Steroid Biochem Mol Biol; 2019 Jun; 190():139-151. PubMed ID: 30923017
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression.
Varghese V; Magnani L; Harada-Shoji N; Mauri F; Szydlo RM; Yao S; Lam EW; Kenny LM
Sci Rep; 2019 Feb; 9(1):1505. PubMed ID: 30728402
[TBL] [Abstract][Full Text] [Related]
20. Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine.
Ma T; Zhu ZG; Ji YB; Zhang Y; Yu YY; Liu BY; Yin HR; Lin YZ
World J Gastroenterol; 2004 Jan; 10(2):172-6. PubMed ID: 14716816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]